| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $125K | +0.0% |
| R&D Expense | $20.8M | +37.0% |
| SG&A Expense | $14.1M | +31.7% |
| Operating Income | -$34.7M | -35.0% |
| Income Tax | $0 | — |
| Net Income | -$18.8M | +48.0% |
| EPS (Basic) | -$0.65 | +66.0% |
| EPS (Diluted) | -$0.65 | +66.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $70.1M | -15.2% |
| Current Assets | $71.9M | -15.3% |
| Total Assets | $77.7M | -12.9% |
| Current Liabilities | $5.6M | +4.7% |
| Total Liabilities | $30.0M | +19.6% |
| Stockholders' Equity | $47.7M | -25.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$31.4M | -41.4% |
| Capital Expenditures | $1.3M | -29.3% |
| Investing Cash Flow | -$1.3M | +29.3% |
| Financing Cash Flow | $20.0M | -72.2% |
| Free Cash Flow | -$32.7M | -36.0% |